Equities

Polaris Group LLC

6550:TAI

Polaris Group LLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)55.90
  • Today's Change-0.40 / -0.71%
  • Shares traded917.25k
  • 1 Year change-32.81%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in TWDView more

In 2023, cash reserves at Polaris Group LLC fell by 3.61bn. Cash Flow from Financing totalled 919.16m or 12,286.61% of revenues. In addition the company used 1.26bn for operations while cash used for investing totalled 3.24bn.
Cash flow per share-2.41
Price/Cash flow per share--
Book value per share9.22
Tangible book value per share6.24
More ▼

Balance sheet in TWDView more

Polaris Group LLC appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio9.86
Quick ratio9.74
Total debt/total equity0.2641
Total debt/total capital0.2065
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.